header image

Abstract submission

Take an active part in the scientific program and submit your results from science and practice on the following topics!

Thank you very much for your interest in the EPHAR 2027 in Frankfurt, Germany.

Submissions can be made online until 7 October.
We look forward to your contributions and thank you in advance for your active participation in the congress!

 

Beware of Phishing! Do not pass on any personal information to companies unknown to you and not clearly identifiable as Conventus. Warning information

Notes on abstract submission

You will find all the necessary information on formatting guidelines, structure and much more for your abstract HERE.
Please follow the guidelines when creating your abstract.

Abstract topics

Submit your results now until 7 October

BASIC RESEARCH

• G-protein coupled receptors
• Receptor tyrosine kinases
• Signal transduction and second messengers
• Nuclear receptors, enzymes and other targets
• Ion channels and membrane transporters
• Drug transport/delivery and metabolism
• Disease models, drug development
• Pharmacokinetics and PK/PD modelling

TEACHING AND EDUCATION

EMERGING TOPICS 

APPLIED PHARMACOLOGY

• Cardiac pharmacology
• Immunopharmacology / inflammation / anti-infectives
• Cancer pharmacology
• CNS pharmacology
• Endocrine pharmacology
• Pharmacogenomics and personalized medicine
• Pharmacoepidemiology and drug safety
• Regulatory pharmacology and toxicology
• Drug toxicology

Your motivation

3 reasons why you should get involved

Your publication

All abstracts will be published open-access and at no additional cost for you in Naunyn-Schmiedeberg‘s Archives of Pharmacology (Springer Nature).

Your platform

Join us in shaping the future of pharmacology. By submitting your abstract you become part of the scientific program & get the chance to share your scientific expertise with your colleagues!

 

Your honour

Your abstract may be selected for various poster prizes and young talent awards.

 

Stefan Regge

Abstract management